Table 4 Outcomes according to estimated glomerular filtration rate
Group I N = 13 | Group II N = 15 | Group III N = 81 | Group IV N = 45 | Group V N = 30 | P | |
|---|---|---|---|---|---|---|
In-hospital outcome | ||||||
Death (%) | 0 | 1 (6.7) | 4 (4.9) | 2 (4.4) | 6 (20) | 0.046 |
Complications (%) | 1 (7.7) | 1 (6.7) | 5 (6.7) | 4 (8.8) | 8 (26.7) | 0.031 |
AKI | 0 | 1 (6.7) | 2 (2.5) | 1 (2.2) | 2 (6.7) | NS |
Cardiogenic shock | 0 | 1 (6.7) | 2 (2.5) | 4 (8.8) | 5 (16.7) | NS |
Major bleeding | 1 (7.7) | 0 | 1 (1.2) | 1 (2.2) | 1 (3.3) | NS |
AV block | 0 | 0 | 1 (1.2) | 2 (4.4) | 4 (13.3) | 0.039 |
VT | 0 | 0 | 1 (1.2) | 2 (4.4) | 4 (13.3) | 0.039 |
Hospital stay (days) | 10.3 ± 10.9 | 19.8 ± 11.9 | 19.9 ± 18.8 | 24.5 ± 28.1 | 29.1 ± 12.5 | 0.042 |
Out-hospital outcome | ||||||
MACE (%) | 1 (7.7) | 2 (13.3) | 7 (8.6) | 5 (11.1) | 10 (33.3) | 0.015 |
Cardiac death | 0 | 0 | 1 (1.2) | 2 (4.4) | 2 (6.7) | NS |
MI | 0 | 1 (6.7) | 1 (1.2) | 2 (4.4) | 5 (16.7) | 0.016 |
Re-PCI | 1 (7.7) | 2 (26.7) | 3 (3.7) | 4 (8.9) | 4 (13.3) | NS |
TVR | 1 (7.7) | 2 (13.3) | 1 (1.2) | 2 (4.4) | 2 (6.7) | NS |
Non-TVR | 0 | 1 (6.7) | 1 (1.2) | 1 (2.2) | 1 (3.3) | NS |
TLR | 0 | 1 (6.7) | 1 (1.2) | 1 (2.2) | 1 (3.3) | NS |
CABG | 0 | 1 (6.7) | 0 () | 1 (2.2) | 1 (3.3) | NS |
Stroke | 1 (7.7) | 0 | 0 | 1 (2.2) | 2 (6.7) | NS |